<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Poelma, D.L.</title>
    <link>http://repub.eur.nl/res/aut/15026/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Effect of SP-B peptides on the uptake of liposomes by alveolar cells (Article)</title>
      <link>http://repub.eur.nl/res/pub/37086/</link>
      <pubDate>2007-06-01T00:00:00Z</pubDate>
      <description>Background: Exogenous surfactant has been accepted worldwide as a therapy of RDS in premature and term infants. Exogenous surfactant is usually derived from lung extracts containing phospholipids and the surfactant proteins SP-B and SP-C. Synthetic peptides of SP-B and SP-C are being tested with the aim to develop a completely synthetic surfactant preparation. Nevertheless, the effects of these peptides on the endogenous surfactant metabolism remain unknown. Objectives: The effect of synthetic SP-B peptides on uptake of surfactant-like liposomes was investigated in alveolar cells. Native SP-B and seven SP-B peptides were included: monomeric and dimeric SP-B1-25(Cys-11 → Ala-11), SP-B63-78and Ala-SP-B63-78(Cys-71 → Ala-71;Cys-77 → Ala-77)and their serine mutants. Methods: In vitro, alveolar macrophages (AM) and alveolar type II cells (ATII) were incubated with liposomes containing SP-B or one of its peptides. In vivo, rats received intratracheally various SP-B peptides (SP-B/lipid ratio 1:33 w/w) incorporated in fluorescent surfactant-like liposomes. One hour after instillation, AM and ATII were isolated and cell-associated fluorescence was determined using flow cytometry. Confocal laser microscopy was performed to ensure internalization of the liposomes. Results: In vitro uptake by AM or ATII was not influenced by the SP-B peptides. In vivo, SP-B1-25and Ser-SP-B1-25increased the uptake by AM whereas dSP-B1-25decreased the uptake. Neither SP-B1-25nor dSP-B1-25affected total uptake by ATII. The overall uptake by SP-B63-78variants was not changed. Conclusions: Surface-active synthetic SP-B peptides do not interfere with the normaluptake of surfactant by ATII. Copyright </description>
    </item> <item>
      <title>Influence of phosphatidylglycerol on the uptake of liposomes by alveolar cells and on lung function. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13648/</link>
      <pubDate>2005-05-01T00:00:00Z</pubDate>
      <description>The effect of phosphatidylglycerol on the uptake of surfactant-like liposomes by alveolar type II cells and alveolar macrophages as well as the effect on endogenous surfactant function was studied in vivo. Healthy ventilated rats were intratracheally instilled with fluorescent labeled liposomes with different concentrations of phosphatidylglycerol. Lung function was determined by monitoring arterial oxygenation and, at the end of the experiment, by recording static pressure-volume curves. In addition, alveolar cells were isolated, and cell-associated fluorescence was determined using flow cytometry. The results show that, in the presence of cofactors (Ca(2+), Mg(2+)), phosphatidylglycerol stimulates the uptake by alveolar macrophages but hardly affects the uptake by alveolar type II cells. High concentrations of phosphatidylglycerol reduce the number of alveolar macrophages in the alveolar space and deteriorate lung function. On the other hand, the presence of cofactors protects the lung against the negative effects of phosphatidylglycerol on endogenous surfactant and alveolar macrophages. This study indicates that the phosphatidylglycerol concentration may play a fundamental role in the surfactant function and metabolism depending on the presence of so-called cofactors like calcium and magnesium; further study is needed to clarify the mechanisms involved.</description>
    </item> <item>
      <title>Distinct effects of SP-B and SP-C on the uptake of surfactant-like liposomes by alveolar cells in vivo and in vitro. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13470/</link>
      <pubDate>2004-11-01T00:00:00Z</pubDate>
      <description>The effects of surfactant protein B (SP-B) and SP-C on the uptake of
      surfactant-like liposomes by alveolar type II cells and alveolar
      macrophages were studied both in vivo and in vitro. In vivo, mechanically
      ventilated rats were intratracheally instilled with fluorescently labeled
      liposomes that had SP-B and/or SP-C incorporated in different
      concentrations. Consequently, the alveolar cells were isolated, and
      cell-associated fluorescence was determined using flow cytometry. The
      results show that the incorporation of SP-B does not influence the uptake,
      and it also does not in the presence of essential cofactors. The inclusion
      of SP-C in the liposomes enhanced the alveolar type II cells at a SP-C to
      lipid ratio of 2:100. If divalent cations (calcium and magnesium) were
      present at physiological concentrations in the liposome suspension, uptake
      of liposomes by alveolar macrophages was also enhanced. In vitro, the
      incorporation of SP-B affected uptake only at a protein-to-lipid ratio of
      8:100, whereas the inclusion of SP-C in the liposomes leads to an
      increased uptake at a protein-to-lipid ratio of 1:100. From these results,
      it can be concluded that SP-B is unlikely to affect uptake of surfactant,
      whereas SP-C in combination with divalent cations and other solutes are
      capable of increasing the uptake.</description>
    </item> <item>
      <title>A common pathway for the uptake of surfactant lipids by alveolar cells. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13267/</link>
      <pubDate>2004-05-01T00:00:00Z</pubDate>
      <description>The uptake of different surfactant lipids-dipalmitoylphosphatidylcholine
      (DPPC), phosphatidylglycerol (PG), or phosphatidylinositol (PI)-and
      liposomes with a surfactant-like composition by alveolar type II cells
      (alveolar type II cells) and macrophages (alveolar macrophages) was
      studied in vitro. Fluorescent-labeled liposomes containing either 86% of
      the studied lipid, i.e., DPPC, PG, PI, and 6% labeled
      phosphatidylethanolamine (PE) and 8% cholesterol or a lipid mixture
      similar to surfactant (DPPC, PG, PI, phosphatidylcholine, PE, and
      cholesterol in a weight ratio of 55:8:2:21:8:6) were incubated with
      alveolar macrophages and alveolar type II cells. The cell-associated
      fluorescence assessed by flow cytometry demonstrated a higher uptake of PG
      and PI by both alveolar macrophages and alveolar type II cells, and a
      lower uptake of DPPC by alveolar macrophages. In addition, fewer alveolar
      type II cells take up DPPC, whereas there are no differences for the
      alveolar macrophages in the number of cells involved in the uptake.
      Competition experiments with Texas Red-labeled liposomes and either DPPC
      liposomes or PI liposomes labeled with Bodipy indicated that all these
      liposomes are internalized via the same pathway by alveolar cells. Thus,
      lipid composition directly influences the (re)uptake of surfactant.</description>
    </item> <item>
      <title>In vivo and in vitro uptake of surfactant lipids by alveolar type II cells and macrophages. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13094/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>The uptake of fluorescent-labeled liposomes (with a surfactant-like
      composition) by alveolar macrophages and alveolar type II cells was
      studied using flow cytometry, in vivo by instillation of the labeled
      liposomes in the trachea of ventilated rats followed by isolation of the
      alveolar cells and determination of the cell-associated fluorescence, and
      in vitro by incubation of isolated alveolar cells with the fluorescent
      liposomes. The results show that the uptake of liposomes by the alveolar
      cells is time and concentration dependent. In vivo alveolar macrophages
      internalize more than three times as many liposomes as alveolar type II
      cells, whereas in vitro, the amount of internalized liposomes by these
      cells is approximately the same. In vitro, practically all the cells
      (70-75%) internalize liposomes, whereas in vivo only 30% of the alveolar
      type II cells ingest liposomes vs. 70% of the alveolar macrophages. These
      results indicate that in vivo, only a small subpopulation of alveolar type
      II cells is able to internalize surfactant liposomes.</description>
    </item>
  </channel>
</rss>